Horizon Discovery – Parkwalk UCEF I exit
We are delighted to have generated a 2.36x return (3.37x inclusive of initial tax reliefs) for our investors on the sale of the University of Cambridge Enterprise Fund I holding in Horizon Discovery plc. The investment was held for… Read More
Sphere Fluidics – Parkwalk closes further funding round
We have closed a follow-on investment in Sphere Fluidics for the Opportunities Fund. This follows the UCEFs investing previously. Sphere Fluidics is an established Life Sciences company which has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D… Read More
Horizon Discovery – Strong Revenue Growth and Focus on Operational Gearing Underpin Path to Profitability
Cambridge, UK, 20 September 2016: Horizon Discovery Group plc (LSE: HZD), a world leader in the application of gene editing technologies, announces its interim results for the six months ended 30 June 2016. Highlights (including post period end):… Read More
Parkwalk portfolio company CCMOSS – acquired by ams AG to become world leader in gas and infrared sensing
ams AG (SIX: AMS), a leading worldwide manufacturer of high performance sensor and analog solutions, has acquired 100% of the shares in Cambridge CMOS Sensors Ltd (CCS), the technology leader in micro hotplate structures for gas sensing and… Read More
DefiniGEN – Parkwalk closes follow on investment
Parkwalk closes DefiniGen investment for the University of Cambridge Enterprise Fund IV and Parkwalk Funds DefiniGEN, a spin-out from the University of Cambridge Regenerative Medicine Department at Addenbrooke’s Hospital, have created a stem cell technology to provide human… Read More
Sphere Fluidics – University of Cambridge Enterprise Fund III closes further funding round
We have closed an investment, in a $7m funding round, in Sphere Fluidics for the University of Cambridge Enterprise Fund III. This follows the UCEFs I and II investing previously. The investment round has been led by an Asian corporate investor Sphere Fluidics… Read More
AQDOT – Follow on Investment
We have recently made a follow-on investment into Aqdot on behalf of the Parkwalk Opportunities EIS Fund and the University of Cambridge Enterprise Fund III. Aqdot is a spin-out from the Department of Chemistry at the University of Cambridge and was… Read More
CCMOSS – Parkwalk closes further funding round
We have recently made an investment in Cambridge CMOS Sensors for the Parkwalk Opportunities EIS Fund and the University of Cambridge Enterprise Fund III.. This follows predecessor funds investing in 2012 and 2013. Cambridge CMOS Sensors is a leading… Read More
Horizon Discovery – Placing to raise approximately £25 million to accelerate the Company’s growth strategy
Horizon Discovery Group plc (LSE:HZD), the international life science company supplying research tools and services that power genomics research and the development of personalised medicines, is pleased to announce a conditional non-pre-emptive placing of 13,157,895 New Placing Shares… Read More
Horizon Discovery – Positive Trading Update
Revenues expected to be ahead of consensus by approximately 7% driven by an increased global demand for expanded product, service and IP offering Cambridge, UK – 19th January 2014: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or the… Read More
Horizon Discovery – acquires Sage Labs Inc. for $48M
Acquisition makes Horizon the world’s leading gene-editing and translational genomics company Highlights · Horizon acquires Sage Labs Inc. for up to $48M (£29M) comprising up to $16M in cash and up to $32M in new ordinary shares · Acquisition creates a… Read More
AQDOT – Follow on Investment
We have recently made a follow-on investment into AQDOT on behalf of the University of Cambridge Enterprise Fund II and the Parkwalk UK Technology Fund V. AQDOT‘s technology allows for an energy- and raw material-efficient way of manufacturing… Read More
Horizon Discovery – Interim Results
Interim Results in-line and Panmure reaffirms ‘Buy Rating’: Interim Results for the Six Months Ended 30 June 2014 Horizon Reports a Strong First Half Positioning the Company for Continued Growth Cambridge, UK, 23 September 2014: Horizon Discovery Group… Read More
DefiniGEN Joins EBiSC Consortium
DefiniGEN (an investment in the University of Cambridge Enterprise Funds I & II), a leading provider of stem cell life science products and services has joined the European Bank for induced pluripotent stem cells (EBiSC) consortium. The consortium… Read More
Horizon Discovery – wins European Mediscience’s Emerging Star Award 2014
Horizon Discovery Group plc, the international life science company supplying research tools to organisations engaged in genomics research and the development of personalised medicines, is delighted to announce that it has won the “Emerging Star” category at last… Read More
Sphere Fluidics – Parkwalk closes further funding round
We have closed an investment, in the first tranche of a financing round of up to £2m, in Sphere Fluidics for the University of Cambridge Enterprise Fund II and the final investment for Parkwalk Fund IV. This follows the UoCEF I… Read More
CCMOSS – Parkwalk closes further funding round
We have recently made an investment in Cambridge CMOS Sensors for the UK Tech Fund V and a Parkwalk Syndicate. This follows predecessor funds investing in 2012 and 2013. Cambridge CMOS Sensors are a leading manufacturer of sensor solutions… Read More
Horizon Discovery Says It Has Continued To Trade Strongly Since IPO
Horizon Discovery Group PLC said Wednesday that it had continued to trade strongly since its initial public offering. The company said it had traded “at least in line with expectations”, and that it is pursuing its strategy to… Read More
Horizon Discovery – Record AIM $113m IPO
Parkwalk portfolio company Horizon Discovery is set to create UK stock market history with a significantly oversubscribed AIM IPO on Thursday March 27, with a market cap of £120.5 million after raising £68.6m from institutional investors against an original target… Read More
